13 August 2021

GSK Stockmann advises Munich Hotel Partners on the acquisition and rebranding of Swissôtel Basel

GSK Stockmann advised Munich Hotel Partners GmbH (MHP) on the acquisition of the former Swissôtel Basel. MHP acquired the building in cooperation with US private equity company H.I.G Capital and concluded a long-term management agreement regarding the hotel operations as part of the joint venture, which was set up in Luxembourg. Furthermore, GSK Stockmann advised MHP on the franchise and all related agreements with Marriott International.

The former Swissôtel Basel will be run in the future as Marriott Hotel Basel. The hotel’s rebranding to the premium brand Marriott will take place after an extensive refurbishment in the coming months. By acquiring a minority stake in the property, MHP is co-investing in the hotel real estate market for the first time, and is thus expanding its business model. The parties agreed not to disclose the purchasing price.

A GSK Stockmann team led by partners Stefan J. Schlapka (Munich) and Philipp Mössner (Luxembourg) advised on the deal. The seamless cooperation between the teams in Germany and Luxembourg has proven again to be advantageous for German clients investing through Luxembourg.

Advisers of Munich Hotel Partners GmbH:

GSK Stockmann: Stefan J. Schlapka, Philipp Mössner (both Real estate transactions, both lead); Associate: Kate Yu Rao (Corporate)

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 03.08.2021

    GSK Update: Cross-Border Distribution Directive implemented – What you should know

    Read more
  • 07.05.2021

    GSK Update: Introducing the new sustainable finance measures of the EU Commission

    Read more
  • 30.03.2021

    GSK Update: SFDR – new RTS – What you should know

    Read more
Contact person

Dr. Philipp Mössner, LL.M.

Partner

+352 271802-40

philipp.moessner@gsk-lux.com

Kate Rao, LL.M.

Senior Associate

+352 271802-54

kate.rao@gsk-lux.com

© GSK Stockmann 2021